| 引用本文: | 李洪1，高玉梅2*，王欣1，王晓欣1.诺氟沙星胃漂浮片处方及体外释放研究[J].中国现代应用药学,2009,(10):840-843. |
| LI Hong1, GAO Yumei2*, WANG Xin1, WANG Xiaoxin1.Formula and in Vitro Release Study of Norfloxacin Intra-gastric Floating Sustained Release Tablets[J].Chin J Mod Appl Pharm(中国现代应用药学),2009,(10):840-843. |
|
|
| 摘要: |
| 目的通过对诺氟沙星胃漂浮片的制备处方研究，考察其漂浮性和体外释放性。方法对处方中辅料的因素水平进行逐一考察，并采用相似因子法比较药物释放曲线的差异。结果HPMC规格对胃漂浮片的释药和持漂时间有明显影响，HPMC K100M用量为120 mg·片-1、碳酸氢钠用量为200 mg·片-1和羧甲基淀粉钠用量为100 mg·片-1时漂浮性能和释放度最佳。结论该处方研制的诺氟沙星胃漂浮片具有良好的漂浮特性和缓释特性。 |
| 关键词: 诺氟沙星 胃漂浮片 处方 体外释放 |
| DOI： |
| 分类号: |
| 基金项目: |
|
| Formula and in Vitro Release Study of Norfloxacin Intra-gastric Floating Sustained Release Tablets |
|
LI Hong1, GAO Yumei2*, WANG Xin1, WANG Xiaoxin1
|
| Abstract: |
| OBJECTIVE Norfloxacin intra-gastric floating sustained-release tablets were formulated and the in vitro release was studied. METHODS The in vitro release was determined and the effects of formulation factors were investigated. The data were analyzed by the statistical method-similar factor method. RESULTS The specification of HPMC affected significantly the sustained-release and continual floating property. The tablets showed a good sustained-release and continual floating property with HPMC K100M 120 mg tablet-1, sodium bicarbonate 200 mg·tablet-1, CMS-Na 100 mg·tablet-1. CONCLUSION The tablets showed a good sustained-release and continual floating property with the formula. |
| Key words: norfloxacin intra-gastric floating sustained-release tablets formula in vitro release |
